Table of contents

Inflammation and inflammatory bowel disease

• Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation (1 April, 1998)

  S Nikolaus, J Bauditz, P Gionchetti, C Witt, H Lochs, S Schreiber
• Activation of nuclear factor κB in inflammatory bowel disease (1 April, 1998)

  S Schreiber, S Nikolaus, J Hampe
• Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease (1 April, 1998)

  B Sido, V Hack, A Hochlehnert, H Lipps, C Herfarth, W Dröge
• Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease (1 April, 1998)

  V Gross, T Andus, K W Ecker, A Raedler, K Loeschke, M Plauth, J Rasenack, A Weber, M Gierend, K Ewe, J Schölmerich, Budesonide Study Group
• Controlled trial of antituberculous chemotherapy in Crohn’s disease: a five year follow up study (1 April, 1998)

  G A O Thomas, G L Swift, J T Green, R G Newcombe, C Braniff-Mathews, J Rhodes, S Wilkinson, G Strohmeyer, G Kreuzpainter